Precision Optics (POCI) Projected to Release Quarterly Earnings on Thursday

Precision Optics (NASDAQ:POCI) will likely be releasing its Q1 2027 results after the market closes on Thursday, November 12th. Analysts expect the company to post earnings of ($0.13) per share and revenue of $6.40 million for the quarter. Individuals can check the company’s upcoming Q1 2027 earnings report for the latest details on the call scheduled for Monday, November 16, 2026 at 5:00 PM ET.

Precision Optics (NASDAQ:POCI) last issued its earnings results on Monday, September 28th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.05. The firm had revenue of $8.77 million for the quarter, compared to the consensus estimate of $7.10 million. Precision Optics had a negative return on equity of 23.92% and a negative net margin of 11.51%.

Precision Optics Stock Up 2.2%

Precision Optics stock opened at $5.00 on Tuesday. The business’s 50-day moving average price is $4.47 and its 200 day moving average price is $4.64. The company has a quick ratio of 1.84, a current ratio of 2.28 and a debt-to-equity ratio of 0.03. The firm has a market cap of $54.95 million, a price-to-earnings ratio of -10.87 and a beta of 0.23. Precision Optics has a 52 week low of $3.55 and a 52 week high of $6.15.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Precision Optics in a research report on Wednesday, September 2nd. Wall Street Zen raised shares of Precision Optics to a “hold” rating in a research note on Saturday, October 3rd. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has an average rating of “Sell”.

Precision Optics Company Profile

Precision Optics Corporation, Inc is a medical technology company that develops and manufactures advanced optical systems and components for minimally invasive medical procedures. The company works primarily with medical device manufacturers, providing specialized imaging technologies designed to support visualization during surgery and other clinical applications.

Its product portfolio includes rigid and flexible endoscopes, three-dimensional endoscopic systems, disposable and reusable visualization devices, surgical cameras, and custom optical assemblies.